Altshuler Shaham LTD Compugen LTD Transaction History

Altshuler Shaham LTD

  • $1.57 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$2.76 - $4.64 $13,242 - $22,262
-4,798 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$6.87 - $9.16 $32,962 - $43,949
4,798 New
4,798 $40,000
Q4 2020

Feb 16, 2021
SELL
$12.07 - $17.95 $3.48 Million - $5.17 Million
-288,262 Closed
0 $0
Q3 2020

Nov 10, 2020
BUY
$14.16 - $19.45 $4.08 Million - $5.61 Million
288,262 New
288,262 $4.75 Million

Others Institutions Holding CGEN

# of Institutions
73
Shares Held
13.1M
Call Options Held
79.2K
Put Options Held
12.7K
View Full List

About COMPUGEN LTD

CGEN Quotes by TradingView
  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $139M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email